SY
Syngene International Limited
SYNGENE.NS · NSE
₹378.60 -1.06% (-₹4.05)
1M -5.05%
Market Cap ₹154.2B
P/E Ratio 69.77x
Div. Yield 0.33%
ROE 4.60%
Bulios Fair Price
₹209.15
44.8% downside
Trenutna cena
₹378.6
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SYNGENE.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
27 /100
Expensive P/E 69.77x
P/B 3.17x
EV/EBITDA 18.98x
Growth
50 /100
Stable EPS growth 11.90%
Book val. growth 10.18%
Rev. growth 5.40%
Profitability
37 /100
Moderate Gross margin 32.49%
FCF margin 5.56%
Net margin 6.14%
Quality
31 /100
Poor ROIC 6.28%
Asset turnover 0.53x
ROE 4.60%
Debt
92 /100
Low Debt/Equity 0.10x
Net debt/EBITDA 0.39x
Current ratio 1.56x
Stability
68 /100
Stable Beta 0.08x
Profitable years 6
Rev. volatility 3.43%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SYNGENE.NS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Siddharth Mittal
Employees
6,692
Headquarters
Bengaluru
Prihajajoči dogodki
21 OKT.
Earnings
Upcoming earnings report